Annals of Emergency Medicine
Volume 53, Issue 4 , Pages 411-417 , April 2009

Pediatric Fatalities Associated With Over the Counter (Nonprescription) Cough and Cold Medications

Presented at the XXVIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists, May 2008, Seville, Spain.

  • Richard C. Dart, MD, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO
    • University of Colorado School of Medicine, Aurora, CO
    • Corresponding Author InformationAddress for correspondence: Richard C. Dart, MD, PhD, Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, 777 Bannock Street, Mail Code 0180, Denver, CO 80204; 303-739-1119, fax 303-739-1443
    • ,
  • Ian M. Paul, MD, MSc

      Affiliations

    • Penn State College of Medicine, Hershey, PA
    • ,
  • G. Randall Bond, MD

      Affiliations

    • Cincinnati Drug and Poison Information Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    • ,
  • David C. Winston, MD, PhD

      Affiliations

    • Pima County Forensic Science Center, Tucson, AZ
    • ,
  • Anthony S. Manoguerra, PharmD

      Affiliations

    • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California–San Diego, La Jolla, CA
    • ,
  • Robert B. Palmer, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO
    • ,
  • Ralph E. Kauffman, MD

      Affiliations

    • University of Missouri–Kansas City School of Medicine, Kansas City, MO
    • ,
  • William Banner, MD, PhD

      Affiliations

    • Oklahoma Poison Control Center, The Children's Hospital at Saint Francis, Department of Pediatrics, Oklahoma University College of Medicine, Tulsa, OK
    • ,
  • Jody L. Green, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO
    • ,
  • Barry H. Rumack, MD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO
    • University of Colorado School of Medicine, Aurora, CO

Received 7 July 2008 ,Revised 25 August 2008 ,Accepted 16 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supervising editors: Michael W. Shannon, MD; Michael L. Callaham, MD

 Dr. Shannon and Dr. Callaham were the supervising editors on this article. Dr. Dart did not participate in the editorial review or decision to publish this article.

 Author contributions: RCD and JLG conceived the study, designed the process, and obtained research funding. RCD and JLG supervised the conduct of the trial and data collection. RCD and JLG recruited panel members and managed the data, including quality control. RCD drafted the article, and all authors group contributed substantially to its revision. RCD takes responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. This research was supported by an investigator-initiated grant from McNeil Consumer Healthcare to Denver Health and Hospital Authority. The panel members received a stipend from Denver Health and Hospital for their participation. The project was proposed and designed by Dr. Dart. The cases in the category of “manufacturer’s adverse events” were identified by each manufacturer individually and supplied to Denver Health. None of the researchers received consultation fees or any other compensation from the manufacturer. McNeil Consumer Products had no input into the design, definitions of causality, panel proceedings, analysis of results or drafting of the article.

 Publication dates: Available online December 19, 2008.

 Reprints not available from the authors.

PII: S0196-0644(08)01779-4

doi: 10.1016/j.annemergmed.2008.09.015

Annals of Emergency Medicine
Volume 53, Issue 4 , Pages 411-417 , April 2009

Article Tools

* Image Usage & Resolution